IMDX - Oncocyte Corp
3.56
-0.550 -15.449%
Share volume: 341,804
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$4.11
-0.55
-0.13%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-15-2024 | 08-08-2024 | 11-12-2024 | 03-24-2025 | 05-12-2025 | 08-11-2025 | 11-10-2025 | 03-26-2026 | |
| Cash flow financing | 0.000 | 9.847 M | -255.000 K | 10.837 M | 28.558 M | -114.000 K | -120.000 K | -252.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 1.550 M | 0.000 | 0.000 | 0.000 | -74.000 K | |
| Cash flow | -3.830 M | 3.678 M | -5.893 M | 5.273 M | 22.393 M | -6.742 M | -5.672 M | -7.276 M | |
| Net income | -9.129 M | -4.530 M | -13.493 M | -33.511 M | -6.671 M | -9.742 M | -10.854 M | -22.955 M | |
| Depreciation | 335.000 K | 304.000 K | 318.000 K | 541.000 K | 484.000 K | 559.000 K | 584.000 K | 563.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 49.000 K | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 161.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -24.000 K | -191.000 K | -87.000 K | -210.000 K | -307.000 K | -349.000 K | -1.050 M | -1.479 M | |
| Net Borrowings | -2.978 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -24.000 K | 191.000 K | 87.000 K | 210.000 K | 307.000 K | 349.000 K | 1.050 M | 1.479 M | |
| Cash Change | 5.578 M | 3.678 M | -5.893 M | 5.273 M | 22.393 M | -6.742 M | -5.777 M | -7.291 M |